Evidence map›Paper›PMID 37427454›Full record

ArticleDisease models & mechanisms2023

LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model.

Brigida Boccanegra, Paola Mantuano, Elena Conte, Alessandro Giovanni Cerchiara, Lisamaura Tulimiero, Raffaella Quarta, Erika Caputo, Francesca Sanarica, Monica Forino, Valeria Spadotto and 4 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Brigida BoccanegraDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.ORCID 0000-0002-1078-8490
Paola MantuanoDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.ORCID 0000-0001-6339-2222
Elena ConteDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.ORCID 0000-0001-8571-5125
Alessandro Giovanni CerchiaraDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.
Lisamaura TulimieroDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.
Raffaella QuartaDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.
Erika CaputoDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.
Francesca SanaricaDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.
Monica ForinoPreclinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, 20092 Milan, Italy.
Valeria SpadottoPreclinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, 20092 Milan, Italy.
Ornella CappellariDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.ORCID 0000-0002-1882-3502
Gianluca FossatiPreclinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, 20092 Milan, Italy.ORCID 0000-0002-0060-5822
Christian SteinkühlerPreclinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, 20092 Milan, Italy.ORCID 0000-0001-8341-9699
Annamaria De LucaDepartment of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70125 Bari, Italy.ORCID 0000-0002-5652-7341
University of Bari Aldo Moro · ITItalfarmaco (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential role of liver kinase B1 (LKB1) in the altered activation of the master metabolic and epigenetic regulator adenosine monophosphate-activated protein kinase (AMPK) in Duchenne muscular dystrophy has not been investigated so far. Hence, we analyzed both gene and protein levels of LKB1 and its related targets in gastrocnemius muscles of adult C57BL/10 mdx mice and D2 mdx mice, a model with a more severe dystrophic phenotype, as well as the sensitivity of the LKB1-AMPK pathway to AMPK activators, such as chronic exercise. Our data show, for the first time, a reduction in the levels of LKB1 and accessory proteins, MO25 and STRADα, in both mdx strains versus the respective wild type, which was further impaired by exercise, in parallel with a lack of further phosphorylation of AMPK. The AMPK-like kinase salt-inducible kinase (SIK) and class II histone deacetylases, along with expression of the HDAC target gene Mef2c, were also altered, supporting an impairment of LKB1-SIK-class II histone deacetylase signaling. Our results demonstrate that LKB1 may be involved in dystrophic progression, paving the way for future preclinical studies.

Indexed as

AMP-Activated Protein KinasesMuscular Dystrophy, DuchenneAnimalsDisease Models, AnimalMiceMice, Inbred C57BLMice, Inbred mdxMuscle, SkeletalProtein Serine-Threonine KinasesAMP-Activated Protein KinasesProtein Serine-Threonine KinasesStk11 protein, mouseAMPKDuchenne muscular dystrophyEpigeneticLKB1Mouse modelsMuscle metabolism

Identifiers

PMID37427454
PMCPMC10354716
OpenAlexW4383711381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.